Four things to know:
1. The healthcare technology company reported $7.7 billion in global revenue for the three-month period ending Jan. 24. That total represents annual growth of 2.3 percent, led by more than 4 percent growth in its restorative therapies business.
2. In the U.S., Medtronic saw revenue gains of just 0.5 percent, to $4 billion, representing about 52 percent of the company’s total revenue.
3. U.S. revenues were also led by about 4 percent growth in the restorative therapies group, while the minimally invasive therapies business reported 0.4 percent year-over-year growth. Both the cardiac and vascular group and diabetes group reported losses in revenue.
4. The quarter was a busy one for Medtronic: During the third quarter of its 2020 fiscal year, the company announced plans to acquire chronic pain treatment technology company Stimgenics, finalized its acquisition of artificial intelligence-enabled analytics software company Klue and formed a health IT partnership with Wilmington, Del.-based ChristianaCare.
More articles on health IT:
IBM Watson Health rolls out new clinical trial design software
Don’t be a ‘data pig’ & 2 more ways to maintain trust while collecting patient data
7 alerts, tools hospitals are adding to their EHRs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
